Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers

Clinical trial NCT02616848 · UNKNOWN

Trial details

NCT number: NCT02616848
Sponsor: Istituti Ospitalieri di Cremona
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Triple Negative Breast Cancer

Start date: 2015-11-01
Primary completion: 2015-11-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.